CD4 and HIV infectious disease: Finally, for the first time based on the new understanding of HIV infection as a chronic inflammatory disease, the 2008 IAS-USA guidelines recommend that HAART should also be offered to all asymptomatic individuals regardless of CD4 cell count if they have an underlying condition or morbidity risk that will be aggravated by untreated HIV infection or that will compromise their future treatment options.